3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
22 21 0 1 0 0 0 0 0999 V2000
1.0485 -1.7492 -0.3782 O 0 0 0 0 0 0 0 0 0 0 0 0
2.1603 -0.4601 1.1202 O 0 0 0 0 0 0 0 0 0 0 0 0
1.6953 1.7283 -0.5330 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.6096 -0.1677 0.2283 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5765 0.9728 0.1218 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7509 0.6119 -0.5642 C 0 0 2 0 0 0 0 0 0 0 0 0
-2.8482 0.3271 0.9813 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0214 -0.7101 -1.1408 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4008 -0.5530 0.1645 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1863 -0.9912 0.8150 H 1 0 0 0 0 0 0 0 0 0 0 0
-1.0301 1.8193 -0.4118 H 1 0 0 0 0 0 0 0 0 0 0 0
-0.3630 1.3320 1.1387 H 1 0 0 0 0 0 0 0 0 0 0 0
0.5910 0.3384 -1.6124 H 1 0 0 0 0 0 0 0 0 0 0 0
-3.3362 1.1500 0.4481 H 1 0 0 0 0 0 0 0 0 0 0 0
-3.5792 -0.4798 1.1006 H 1 0 0 0 0 0 0 0 0 0 0 0
-2.5794 0.6827 1.9817 H 1 0 0 0 0 0 0 0 0 0 0 0
-2.4320 0.0851 -1.7724 H 1 0 0 0 0 0 0 0 0 0 0 0
-1.1801 -1.1617 -1.6726 H 1 0 0 0 0 0 0 0 0 0 0 0
-2.7896 -1.4839 -1.0344 H 1 0 0 0 0 0 0 0 0 0 0 0
1.2841 2.5353 -1.0005 H 0 0 0 0 0 0 0 0 0 0 0 0
2.5300 1.4858 -1.0657 H 0 0 0 0 0 0 0 0 0 0 0 0
1.4695 -2.5010 0.0907 H 0 0 0 0 0 0 0 0 0 0 0 0
1 9 1 0 0 0 0
1 22 1 0 0 0 0
2 9 2 0 0 0 0
3 6 1 0 0 0 0
3 20 1 0 0 0 0
3 21 1 0 0 0 0
4 5 1 0 0 0 0
4 7 1 0 0 0 0
4 8 1 0 0 0 0
4 10 1 0 0 0 0
5 6 1 0 0 0 0
5 11 1 0 0 0 0
5 12 1 0 0 0 0
6 9 1 0 0 0 0
6 13 1 0 0 0 0
7 14 1 0 0 0 0
7 15 1 0 0 0 0
7 16 1 0 0 0 0
8 17 1 0 0 0 0
8 18 1 0 0 0 0
8 19 1 0 0 0 0
M ISO 8 10 2 11 2 12 2 13 2 14 2 15 2 16 2 17 2
M ISO 2 18 2 19 2
4. 国际命名与标识
4.1 IUPAC Name
(2R)-2-amino-2,3,3,4,5,5,5-heptadeuterio-4-(trideuteriomethyl)pentanoic acid
4.2 InChl
InChI=1S/C6H13NO2/c1-4(2)3-5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)/t5-/m1/s1/i1D3,2D3,3D2,4D,5D
4.3 InChlKey
ROHFNLRQFUQHCH-MSQIRGOSSA-N
4.4 Canonical SMILES
CC(C)CC(C(=O)O)N
4.5 lsomeric SMILES
[2H][C@](C(=O)O)(C([2H])([2H])C([2H])(C([2H])([2H])[2H])C([2H])([2H])[2H])N
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病